Rubius Therapeutics Inc (OTC Pink - Limited Information:RUBY)
| 0.0186 Delayed Data As of May 31 |  -0.0044 / -19.13%Today’s Change | 0.01 Today|||52-Week Range 1.57 | -89.37% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 2 2018 | Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | |||
| Assets | Cash | 117.0M | 354.9M | 307.7M | 192.6M | |
| Short Term Investment Cash | -19.5M | 237.9M | -46.6M | -115.1M | ||
| Cash & Short Term Investments | 181.9M | 409.0M | 404.7M | 379.0M | ||
| Receivables | Receivables | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Inventories | Inventories | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Current Assets | Other Current Assets | 965.0K | 3.5M | 9.7M | 6.8M | |
| Current Assets | 182.8M | 412.5M | 414.4M | 385.8M | ||
| Total Assets | Property, Plant and Equipment - Gross | 22.2M | 40.7M | 64.6M | 56.2M | |
| Depreciation | -1.1M | -1.5M | -1.8M | -2.5M | ||
| Other Assets | 2.5M | 0.00 | 168.0K | 138.0K | ||
| Total Assets | 207.5M | 452.8M | 479.1M | 441.5M | ||
| Liabilities | Accounts Payable | 7.0M | 4.5M | 7.9M | 10.2M | |
| Short Term Debt | 2.8M | 4.7M | 4.5M | 4.5M | ||
| Accrued Expenses | 1.9M | 3.5M | 2.3M | 1.6M | ||
| Other Current Liabilities | 2.0M | 3.8M | 4.2M | 4.8M | ||
| Other Liabilities | 14.9M | 16.0M | 20.0M | 20.7M | ||
| Total Liabilities | Long Term Debt | 19.6M | 25.5M | 65.8M | 48.5M | |
| Other Liabilities | 2.8M | 144.0K | 143.0K | 506.0K | ||
| Total Liabilities | 37.2M | 41.6M | 85.9M | 69.7M | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 240.8M | 0.00 | 0.00 | 0.00 | ||
| Common Equity | -70.7M | 411.0M | 393.0M | 371.6M | ||
| Total Shareholder Equity | 170.1M | 411.0M | 393.0M | 371.6M | ||
| Share Information | Common Shares Outstanding | 15.0M | 79.0M | 79.2M | 79.9M | |
| Addtl. Info. | No data currently available for this section. | |||||
